You searched for "refractive"

2195 results found

Demodex blepharitis: A transatlantic comparison of treatments available in the UK and US

Demodex blepharitis is widely recognised among eyecare professionals as an important cause of chronic lid margin inflammation, dry eye and ocular surface diseases. The characteristic feature for diagnosis is the presence of waxy deposit at the lash bases on slit...

The College welcomes inclusion of optometry in NHS England’s strategic commissioning framework

Last week, NHS England published a new framework that sets out what it expects from integrated care boards (ICBs) in the strategic commissioner role, and what ICBs and providers can expect from NHS England, as part of a step-by-step guide...

Record rise in competition ratios for ophthalmology: What does this mean for the future of the ophthalmology training programme?

In this article, Adina Smith discusses factors likely to contribute to the record rise in competition ratios and the impact this may have on the future of OST. Ophthalmology specialty training (OST) is the fifth most competitive training programme in...

COECSA-RCOphth LINK Partnership: Knowledge sharing from the conference scene

Nick Astbury caught up with President of the Ophthalmology Society of Uganda (OSU), Faith Nakubulwa, and Angela Birungi, Scientific Chair for OSU, to discuss their key learnings taken away from the RCOphth 2026. Nick Astbury (NA): One of the key...

Strategies for managing neovascular AMD and DMO in routine clinical care

Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...

Guide to Gaining Approval for a Clinical Study

This article focuses on gaining approval for clinical research involving NHS patients, although the principles can be applied to other types of research. The intention is to give an overview of the requirements for setting up a research study, but...

Back-to-back congresses in Africa highlight international collaboration to advance eye health

The ISOO Africa 2023 Congress The first International Society of Ocular Oncology (ISOO) [1] conference to be held in Africa took place in Mombasa, Kenya, from 21-23 August 2023. Participants came from all over Africa, as well as the US,...

General purpose AI: Transitioning from high performance in highly curated settings to useful applications in ophthalmology

Artificial intelligence (AI) may be understood as the ability of machines to perform tasks which otherwise require human perception, reasoning, or learning. With the advent of deep learning, AI has achieved remarkable results across a wide range of medical tasks...

Paediatric spectacle dispensing: more than a frame and lenses

It’s incredibly rewarding to fit a child’s first pair of spectacles and see their face light up; looking around to see the wider world for the first time. Sometimes it is so obvious that even the most reluctant parent will...

The future of SLT?

For Feb/Mar 2024, we are looking at a recently released laser machine to perform direct SLT – selective laser trabeculoplasty (DSLT). Although SLT is well known, DSLT is sufficiently novel that a brief description is a good place to start....

Orthoptist takes office as Master of The Worshipful Company of Spectacle Makers

In what she called “a giant leap for orthoptists”, Liz Shilling (known professionally as Liz Tomlin), was installed this week as Master of The Worshipful Company of Spectacle Makers, the first orthoptist ever to serve as Master in the Company’s almost 400 year-old history.